We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Heart Disease Risk Linked to Mitochondrial Mutation

By Biotechdaily staff writers
Posted on 16 Nov 2004
Researchers have identified a mutation in the mitochondrial genome that is expressed in people with high blood pressure and elevated cholesterol levels, which are risk factors for cardiovascular disease.

Investigators at Yale University (New Haven, CT, USA) and Syracuse University (NY, USA) worked with a large family (142 individuals spanning four generations) that had many members suffering from a syndrome that included hypertension, hypercholesterolemia, and hypomagnesemia. More...
The syndrome was transmitted by the female relatives with a pattern indicative of mitochondrial inheritance.

Studying the mitochondrial DNA from the female members of the family, the investigators reported in October 21, 2004, online edition of Science Express that they had identified a homoplasmic mutation substituting cytidine for uridine adjacent to the mitochondrial tRNA-Ile anticodon. Uridine is almost always found at this position in tRNAs, as it aids in stabilizing the anticodon loop. Since mitochondrial function is known to decrease with aging in parallel with increasing likelihood of developing cardiovascular diseases, the authors speculate that mutations in mitochondrial DNA may be involved.

"Looking further, this finding raises the possibility that all features of the metabolic syndrome may be attributable to altered mitochondrial function,” said senior author Dr. Richard T. Lifton, professor of genetics at Yale University.

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
All-in-One Molecular System
AIO M160
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.